Cambridge Investment Research Advisors, Inc. Abb Vie Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$26 Billion
Q1 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 479,210 shares of ABBV stock, worth $82.2 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

479,210

Previous 487,742 1.75%

Holding current value

$82.2 Million

Previous $75.6 Million 15.45%

% of portfolio

0.34%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $1.36 Million - $1.55 Million	-8,532 Reduced 1.75%	479,210 $87.3 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $6.19 Million - $6.97 Million	-44,986 Reduced 8.44%	487,742 $75.6 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $3.17 Million - $3.66 Million	23,693 Added 4.65%	532,728 $79.4 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $1.33 Million - $1.66 Million	-10,060 Reduced 1.94%	509,035 $68.6 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $3.88 Million - $4.47 Million	-26,828 Reduced 4.91%	519,095 $82.7 Million

Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $1.42 Million - $1.71 Million	10,284 Added 1.92%	545,923 $88.2 Million
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $3.06 Million - $3.51 Million	22,820 Added 4.45%	535,639 $71.9 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $3.4 Million - $4.33 Million	-24,732 Reduced 4.6%	512,819 $78.5 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $1.77 Million - $2.19 Million	13,392 Added 2.55%	537,551 $87.1 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $974,067 - $1.23 Million	-9,067 Reduced 1.7%	524,159 $71 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $2.06 Million - $2.34 Million	19,349 Added 3.77%	533,226 $57.5 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $2.85 Million - $3.18 Million	27,127 Added 5.57%	513,877 $57.9 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $5.55 Million - $6.11 Million	54,226 Added 12.54%	486,750 $52.7 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $979,965 - $1.32 Million	-12,175 Reduced 2.74%	432,524 $46.3 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $2.66 Million - $3.12 Million	30,912 Added 7.47%	444,699 $39 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $2.98 Million - $3.99 Million	40,600 Added 10.88%	413,787 $40.6 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $1.6 Million - $2.43 Million	24,827 Added 7.13%	373,187 $28.4 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $2.33 Million - $2.91 Million	32,250 Added 10.2%	348,360 $30.8 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $3.45 Million - $4.14 Million	54,702 Added 20.93%	316,110 $23.9 Million
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $9,132 - $10,979	-145 Reduced 0.06%	261,408 $19.8 Million
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $1.89 Million - $2.41 Million	28,699 Added 12.32%	261,553 $0
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $649,673 - $764,633	8,422 Added 3.75%	232,854 $0
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $688,194 - $848,728	8,840 Added 4.1%	224,432 $20.7 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $903,592 - $1 Million	10,163 Added 4.95%	215,592 $0
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $77,210 - $91,357	860 Added 0.42%	205,429 $0
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $226,712 - $303,589	2,464 Added 1.22%	204,569 $0
Q4 2017 Feb 22, 2018	BUY	$89.56 - $98.21 $1.71 Million - $1.88 Million	19,119 Added 10.45%	202,105 $0
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $925,652 - $1.18 Million	-13,252 Reduced 6.75%	182,986 $16.3 Million
Q2 2017 Aug 08, 2017	BUY	N/A	196,238	196,238 $14.2 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Abb Vie Inc. Transaction History